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ABSTRACT 
 
Our laboratory has previously invented and characterized a technique for 
studying ligand-receptor interactions on supported lipid bilayers (SLBs) without 
fluorescently labeled analytes. This technique utilizes a pH-sensitive dye labeled 
phospholipid, ortho-rhodamine B conjugated POPE (1-hexadecanoyl-2-(9Z-octa-
decenoyl)-sn-glycero-3-phosphoethanolamine), as a membrane imbedded reporter 
molecule to monitor ligand-receptor interactions on SLBs by measuring the fluorescence 
intensity change. Also, this technique has been demonstrated to operate as either a “turn-
on” or a “turn-off” sensor depending on the analytes to be detected. Based on these 
preliminary studies, it is necessary to give further development and application for this new 
technique. 
Firstly, as a potential application of this sensing technique, we utilized this 
sensing platform to detect the interactions between tetracaine, a positively charged small 
molecule used as a local anesthetic drug, and planar supported lipid bilayers (SLBs). 
Studies with membranes composed of POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine) yielded an equilibrium dissociation constant value of Kd = 180±47 µm 
for this small molecule-membrane interaction. And the influences of cholesterol, 
phosphatidylethanolamine, and three negatively charged lipids on the interaction 
between tetracaine and the bilayers have been studied. 
Secondly, in order to fully develop the power of this local pH modulation 
technique, it has been extended to a homogeneous platform from an SLB based 
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heterogeneous platform. Specifically, a pH sensitive dye, 5-(and-6)-carboxyfluorescein, 
was conjugated to free lysine residues on the surfaces of designated capture proteins. 
The fluorescein intensity was found to change upon target molecule binding. The assay 
was used to follow the binding of immunoglobulin G (IgG) to streptavidin, thiamin 
monophosphate (ThMP) to thiamin binding protein A (TbpA), and Ca
2+
 to calmodulin 
(CaM).  
Finally, as an instrumental development for this sensing platform, an inexpensive 
fluorescence detector has been built as a cheap substitute for the epi-fluorescence 
microscope. This device is composed of a compact camera, a schott glass color filter, 
and a green (532 nm) laser pointer. This device has been tested to be able to obtain 
fluorescence images with decent signal to noise ratio. And this device has been 
demonstrated in measuring tetracaine-POPC SLB interaction using local pH modulation 
method. 
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CHAPTER I  
INTRODUCTION 
Background 
Cell membrane (Figure 1.1), majorly composed of phospholipids, plays 
important role in cell function and architecture. It protects the cell from its surroundings 
and supports the embedded proteins. Moreover, through a variety of ligand-receptor 
interactions, it participates in all kinds of cellular processes such as cell adhesion and 
cell signaling, which are important for the proper function of a living cell.
1, 2
  As a result, 
being able to monitor ligand-receptor interactions on the cell membrane promotes the 
understanding of some biological phenomenon and may help discover a broad range of 
pharmaceuticals with different functions, such as the study of the polyvalent interaction 
that enables the attachment of an influenza virus to a target cell
3
 and the study of 
interaction between antimicrobial peptide and phospholipid membranes
4, 5
. As 
demonstrated by some of our group’s work, fluorescence technique gives a highly 
sensitive method in observing these interactions on membrane, which requires the 
labeling of the protein or peptide.
6-8
 Proteins with relative big size might not be affected 
on its function or activity, as those labeled dye molecules could be located at the places 
that are not crucial to the protein function. However, for small proteins and peptides, 
fluorescent dye molecules could have altered the structure and the function of the protein 
or peptide, which in turn voids the assay’s result.9 Also, the high cost for some photo-
stable and bright dye molecules as well as the time effort in labeling and separation 
process make this technique less not efficient.
10, 11
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Figure 1.1. Schematic Diagram of Cell Membrane. The graph schematically 
illustrates a cell membrane with common components, including phospholipid, 
glycolipid, cholesterol and some membrane associated proteins. 
  
  
 3 
 
To address these deficiencies of this fluorescence technique based on dye 
labeling, various methods have been developed and applied on detecting ligand-receptor 
interaction on model cell membranes. These methods include the use of Surface Plasmon 
Resonance (SPR),
12-15
 Surface Enhanced Raman Scattering (SERS),
16, 17
 Quartz Crystal 
Microbalance with Dissipation monitoring (QCM-D),
18, 19
 micro-cantilevers,
20, 21
 micro-
calorimetry
22
, Second Harmonic Generation (SHG),
23
 Sum Frequency Generation 
Vibrational Spectroscopy (SFG-VS)
24
, and so on. Although these techniques in deed 
provide alternative label-free ways in detecting membrane based ligand-receptor 
interaction, they can be costly, less efficient, less sensitive, and difficult to be applied in 
membranes based studies.  
Recently, a label-free fluorescence based technique has been invented and 
characterized in our group, which monitors the ligand-receptor interaction on supported 
lipid bilayer (SLB),
25
 a model membrane formed on the surface of borosilicate glass 
cover slips.
26
 Specifically, a pH sensitive dye, ortho-conjugated Texas Red DHPE was 
incorporated into an SLB. Ortho isoform of this fluorescent dye loses its fluorescence 
intensity upon de-protonation under high environment pH. On the other hand, para 
isoform of this molecule gives no response to the environment pH, which serves as a 
good reference. Also, any ligand molecule that could be linked to a lipid molecule, such 
as biotin-PE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) 
(sodium salt)), could be accommodated inside the SLB.  Upon the binding of the target 
molecule, such as anti-biotin IgG, increased fluorescence intensity could be observed. 
The assay shows the sensitivity with 5 orders of magnitude lower than Kd. Later on, 
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Robison et al.
27
 have demonstrated that a different dye, ortho-conjugated Rhodamine B, 
could also be utilized in this assay, which has lower pKa that is closer to physiological 
pH. And this assay could be run in either turn-on mode or turn-off mode, depending on 
the charge status on the target molecule. By manipulating the ionic strength of the 
operating buffer, it is also possible to widen the sensing pH range in order to 
accommodate more target molecules with different pKa values. 
Objective 
Considering the advantages that have been demonstrated by previous group 
members of this pH modulation technique, it is necessary to give further development 
and find possible real applications on it. Firstly, a great number of small drug molecules 
currently on the market target membrane localized proteins, such as receptors and ion 
channels.
28, 29
 These molecules can also directly or indirectly interact with the 
surrounding lipid membrane,
30-33
 which may lead to changes in a drug’s function and 
properties.
34
 Thus, it is important to understand the intrinsic interactions between drug 
molecules and lipid membranes. As most drugs are small molecules, whose properties 
may be altered greatly upon fluorescent labeling, it is imperative to employ label free 
methods to study small molecule-membrane interactions. Thus, we wish to utilize the 
fluorescence based pH modulation technique as a simple and novel label free method to 
observe the interaction between drug molecules and model lipid bilayer and extract 
thermodynamic data. On the other hand, considering new drug development industry 
might be most in need of such a technique that could help screen out the most useful new 
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drug molecule, flow cell with patterned SLBs is utilized. This enables the potential to 
explore multiple membrane interactions on the same device at the same time. 
Secondly, measurements of the affinity between biomolecules, such as protein-
protein interactions, protein-small molecule interactions, and protein-ion interactions not 
only provide insight into basic cellular processes but can also facilitate the development 
of therapeutics and serve as the basis for many diagnostic techniques.
35
 Homogeneous 
methods, such as ITC, have been commonly utilized. However, in the case of small 
molecule weakly binding, the heat generated could be very tiny that might not be 
detected. While for Interfacial methods, such as Surface Plasmon Resonance (SPR),
36, 37
 
microcantilever sensing,
38
 and nanowire sensing,
39
 the requirement of immobilizing 
biomolecules onto surfaces can potentially cause problems even though they permit 
detection down to the pM level and sometimes below it. For example, the receptor sites 
on a protein might face the surface, inhibiting the binding process. Also, surface 
immobilization could alter the conformation and activity of the immobilized protein via 
partial or complete denaturation.
40
 As such, we were wondering whether it is able to 
extend and develop our interfaced based sensing platform to a solution based 
homogeneous sensing platform, enabling the sensing of these interactions. In this extended 
sensing platform, the protein works as the matrix like the SLB, while the binding pocket 
works as the ligand that was accommodated in the bilayer. The pH sensitive dyes get 
randomly labeled to the free amines on the protein backbone in sensing the local pH change 
that might be induced by the binding event. 
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Finally, the device that we utilized for monitoring the fluorescence intensity of those 
label-free assays was fluorescence microscope. However, a fluorescence microscope is 
very expensive that costs tens of thousands of dollars. Also, the size and weight of a 
fluorescence microscope make it very inconvenient to carry out a fluorescence intensity 
measurement outside the lab. With a brief research over the web, the commercialized 
cameras, schott glass filters, and the laser pointers has been so well developed with 
pretty low price on market. Actually, these things could be good substitute for key 
components in a fluorescence microscope. Also, the schott glass filters and the COMS 
chip in a camera have been reported to be successfully integrated onto hand-held 
devices.
41-43
 Thus, we were engaging in designing and building up a family affordable 
and portable fluorescence detector cost under couple hundred dollars. 
Supported Lipid Bilayers 
Supported lipid bilayers (SLBs), as shown in Figure 1.2, are one of the model cell 
membrane systems. They have been widely used as model cell membranes in vitro,
44, 45
 as 
they have the similar lipid composition and could maintain the two-dimensional lipid 
fluidity.
26
 Moreover, their composition could be modulated to accommodate certain 
ligands, phospholipid, and other species. The SLBs could be formed through a 
spontaneous fusion method with high repeatability.
46, 47
 The size of the SLBs are around 
40-50 Å in thickness with a central lipid hydrocarbon chain around 30 Å and a thin 
water layer (10-20 Å) existing between the lower leaflet and the solid support.
48-50
 They 
could be put in microfluidic devices51 or patterned52, 53 in a flow cell, enabling the 
multiplexed assays.  
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Figure 1.2. Schematic Diagram of a Supported Lipid Bilayer. The substrate in the 
all the experiment here is borosilicate glass. A thin water layer that is around 1-2 nm 
thick underneath the bilayer helps keep the two dimensional fluidity of the lipid bilayer.  
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Microfluidics and Flow Cells 
Microfluidic devices have been widely utilized in the field of drug discovery,54 
proteomics,55 neural cell biology,56 et al. In our group, we utilize Polydimethylsiloxane 
(PDMS) to fabricate microfluidic devices in a rapid way.57 Briefly, a PDMS mold is 
fabricated via soft lithographic techniques.58 With its channel size in less than several 
hundred microns both in length and depth, it requires very small sample volumes to fill up 
the whole channel. In addition, with the multiple (usually 2-7) integrated channels on a 
single microfluidic device, it offers the advantage of multiplexing many bilayer studies 
simultaneously, which could greatly save the time and effort in taking assays under different 
conditions. Also, set a channel as a standard for the illumination control will help reduce the 
noise coming from the temporal unstable illumination from the lamp.  
Another device designed for the sensing platform is a flow cell made of circular 
PDMS wells. Patterned lipid bilayer could be made in the well, enabling the multiplexed 
sensing. Although a flow cell has relatively large dead volume and longer sensing time 
compared to a microfluidic device, it helps to avoid some potential problems caused by 
PDMS.59 
Previously, when the target molecules are labeled by dye molecules in bilayer 
studies in microfluidics, the unbounded target molecules in bulk solution could give huge 
fluorescence background. In order to reduce this background, total internal reflection 
fluorescence microscopy (TIRFM) was utilized. 7, 8, 60 However, TIRFM requires lots of 
extra set up compared to an epi-fluorescence microscopy. For example, it requires a laser 
with correct wavelength and a line generator that can give a straight line shaped illumination 
over the multiple channels on the microfluidic device. Also, a dove prism is needed to adjust 
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the illumination angle to achieve total internal reflection. Besides, between the dove prism 
and the microfluidic device, index matching oil needs to be utilized, which makes the device 
slippery and difficult to be fixed in place. With the development of previously descripted 
label free pH modulation technique, it is possible to switch back to a common epi-
fluorescence microscopy with the device located on the sample stage. The mounted mercury 
lamp and the filter set could be used for the fluorescence excitation illumination, while the 
mounted deep cooled CCD camera could be utilized to monitor the fluorescence intensity. A 
gradient flow is adopted for the flushing and switching of the solutions in the device. The 
schematic set up is shown in Figure 1.3.  
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Figure 1.3. Schematic Diagram of the Sensing System Set up. The buffer is flowed 
into the device mounted on the sample stage though gradient force. The flow speed 
could be adjusted by the height of the buffer stage. The fluorescence intensity of the 
device is monitored in real time by an epi-fluorescence microscopy. The drawing is not 
to scale. 
  
  
  
 11 
 
CHAPTER II 
EXPERIMENTAL PROCEDURES AND METHODS* 
Materials 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-(1'-rac-glycerol) (sodium salt) (POPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-L-serine (sodium salt) (POPS), ganglioside GM1 and cholesterol were 
purchased from Avanti Polar Lipids (Alabaster, AL). The chemical structure of all the 
lipids utilized here, including ortho-rhodamine B conjugated POPE (oRB-PE) and ortho-
rhodamine B conjugated biotin (oRB-biotin) are shown in Figure 2.1. The preparation of 
oRB-PE and oRB-biotin are described in the next section.  
Lissamine rhodamine B sulfonyl chloride (mixed isomers) (Figure 2.2(a)) were 
purchased from Invitrogen (Eugene, OR). (5-and-6)-carboxyfluorescein, succinimidyl 
esters (mixed isomers) (5(6)-FAM-SE) (Figure 2.2(b)) were purchased from Invitrogen 
(Carlsbad, CA). Tetracaine came from Sigma-Aldrich (Saint Louis, Missouri). 
Fibrinogen came from MP Biomedicals (Solon, OH).  
  
_________________________________________ 
* Part of the data reported in this chapter is reprinted with permission from Biosens. 
Bioelectron., 38, Huang, D.; Robison, A. D.; Liu, Y.; Cremer, P. S., “Monitoring 
protein–small molecule interactions by local pH modulation”, 74-78, Copyright 2012, 
with permission from Elsevier. 
* Part of the data reported in this chapter is reprinted with permission from “Sensing 
Small Molecule Interactions with Lipid Membranes by Local pH Modulation” by Huang, 
D.; Zhao, T.; Xu, W.; Yang, T.; Cremer, P. S. Anal. Chem. [Online early access]. DOI: 
10.1021/ac401955t. Published Online: Oct. 23, 2013. Copyright 2013 American 
Chemical Society. 
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Figure 2.1. Structures of Lipid Utilized in Drug-Membrane Interaction Study. They 
are (a) POPC, (b) POPE, (c) POPG, (d) POPS, (e) oRB-PE, and (g) oRB-biotin. 
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Figure 2.2. Structure of Two Dye Molecules. The figure shows the structure of (a) 
lissamine rhodamine B sulfonyl chloride (mixed isomers) and (b) (5-and-6)-
carboxyfluorescein, succinimidyl esters (mixed isomers). 
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Native recombinant Staphylococcal aureus Protein A was obtained from Syd 
Labs (Malden, MA). Human IgG, bovine calmodulin and thiamin monophosphate were 
purchased from Sigma-Aldrich (St. Louis, MO). Bovine calmodulin and thiamin 
monophosphate were purchased from Sigma-Aldrich (St. Louis, MO). Thiamin binding 
protein A was supplied by the Begley laboratory at TAMU. Bio-Spin columns with Bio-
Gel P-6 were obtained from Bio-Rad (Hercules, CA). Hydrofluoric acid is from EMD 
(Philadelphia, PA). Ammonium fluoride was obtained from Alfa Aesar (Ward Hill, MA). 
Purified water was produced from a NANOpure Ultrapure Water System (18.2 
MΩ·cm, Barnstead, Dubuque, IA). Microscope slides (25 ×75 ×1.0 mm) were obtained 
from Fisher Scientific (Pittsburgh, PA). Glass coverslips (24 × 40 mm, No. 1.5) were 
from Corning Inc. (Corning, NY). PDMS was purchased from Krayden, Inc (El Paso, 
TX). Thin layer chromatography (TLC) plates (silica gel 60 F254) were obtained from 
EMD (Philadelphia, PA). Polytetrafluoroethylene (PTFE) tubing (inner diameter 
approximately 0.66 mm) was purchased from Newark/element 14 (Palatine, IL). Schott 
colored glass filter (25.4 mm Diameter, Cut-on 570 nm, OG.570) was purchased from 
Newport (Bozeman, MT). 532 nm laser pointer was obtained from Newegg Inc. 
(Whittier, CA).  
Experimental for Sensing Small Molecule and Membrane Interactions 
Rhodamine B-POPE and Rhodamine B-Biotin Preparation and Purification. 10 
mg rhodamine B sulfonyl chloride dissolved in 1 ml anhydrous chloroform was added 
drop by drop to 10 mg/ml POPE in chloroform in an ice bath. After this, 2 μL 
triethylamine was added to the mixed solution. The reaction was stirred for 4 hours at 
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room temperature. After the reaction, the mixture was spotted onto a TLC plate (EMD, 
5715-7, silica gel 60 F254), blown dry with nitrogen gas, and developed with a 
chloroform-methanol mixture (92:8 by volume) to separate rhodamine-B labeled POPE 
mixed isomers from the reactants. The rhodamine B-POPE mixed isomers were then 
separated from each other on another TLC plate developed with a mixture of ammonium 
hydroxide solution, dichloromethane, and n-propanol (5:60:35 by volume). Each 
separated band on the TLC plate was scratched off with a razor blade and collected onto 
a column. A mixture of chloroform and methanol (7:3 by volume) was utilized to elute 
the dye-conjugated lipids from the surface. The concentration of each isomer of 
rhodamine B-conjugated POPE was measured by UV-Vis.  
The preparation and purification of the oRB-biotin conjugate was done in a 
manner analogous to the preparation of oRB-POPE. In this case, 5 mg/ml pentylamine-
biotin (Fisher Scientific, Pittsburgh, PA) was used instead of POPE. 
Small Unilamellar Vesicles (SUVs) Preparation. Lipids were mixed at the 
desired mole ratio in chloroform in a glass vial. Afterward, the chloroform was removed 
by continuous purging with nitrogen. Desiccation was then performed under vacuum for 
more than 2 h to remove any residual organic solvent. The dried lipid films were 
hydrated with 10 mM phosphate-buffered saline (PBS) containing 150 mM NaCl, 
followed by sonication in a bath to obtain 0.5 mg/ml lipid suspensions. These 
suspensions were then subjected to at least 7 freeze-thaw cycles with liquid nitrogen and 
water (room temperature) and at least 7 extrusion cycles through two stacked 100 nm 
polycarbonate membranes (Whatman) using a Lipex extruder (Northern Lipids Inc. 
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Vancouver, Canada). The size of the lipid vesicles was about 95 ± 10 nm as determined 
by dynamic light scattering measurements (Brookhaven Instruments 90Plus Particle Size 
Analyzer). The newly prepared SUV solutions were stored at 4 °C until use.   
Cover Slip Treatment Procedure. All glass cover slips employed for bilayer 
formation were first cleaned in a near boiling mixture of ICN 7X detergent (Costa Mesa, 
CA) and purified water (1:4 volume ratio), followed by rinsing the cover slips 
sequentially with purified water and ethanol at least 3 times. The coverslips were then 
dried under flowing nitrogen and annealed at 530 °C for 5 h in a kiln (Sentry Xpress 2.0, 
Orton Ceramic Foundation, OH), which render the surface of the glass smooth and 
hydrophilic. 
Flow Cell Fabrication. For a flow cell device, as shown in Figure 2.3, a 
polydimethylsiloxane (PDMS) cover block served as the ceiling of the device. Two 
small holes in this block served as inlet and outlet ports for flowing liquid. The PDMS 
block was placed directly over a second thin PDMS film (0.52-0.64 mm) with an 8 mm 
diameter hole in the middle that defined the exposed area of a No. 2 glass coverslip 
placed beneath it. Flowing aqueous solutions came into contact with this exposed area. 
Two thin stainless steel plates (6.5 cm by 3.0 cm) with a 1.0 cm diameter hole in the 
center clamped the entire flow cell together.  
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Figure 2.3. Schematic Diagram of a Flow Cell for Drug Assays. The size of the 
stainless steel plate is 6.5 cm by 3 cm, with the center round window at 1 cm in diameter. 
The PDMS cover block, PDMS well and coverslip fit right in between those two 
stainless steel plates. The SLB is coated on the lower glass slide. The drawing is not to 
scale. 
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The thin PDMS film used in the flow cell was fabricated by curing PDMS in 
between two silanized glass plates with a spacer of 4 stacked No. 1 cover slips (100-150 
μm thick) and trimmed to the correct size to fit the flow cell. A round section was cut out 
to form the well. The thicker PDMS cover block was made the same way except that a 4 
mm thick spacer was used instead. Two holes were reamed into this block by the tip of a 
hollow needle. 
PDMS Stamp and Patterned SLBs. After placing the thin PDMS film on a cover 
slip surface, lipid bilayers were patterned in stripes onto the glass inside the circular 
PDMS hole. Such patterning provided a simple method for comparing signal changes in 
the SLBs with the background fluorescence intensity during an experiment. To do this, a 
PDMS stamp was formed by curing initially uncrosslinked PDMS overnight over a 
patterned glass mold at room temperature,
61
 which is similar to the preparation of the 
PDMS for the microfluidic device. The glass mold had a series of 380 μm × 1 cm 
parallel lines spaced 200 μm from each other that were fabricated by HF etching. The 
PDMS stamp was then cut into appropriately sized sections that would just fit inside the 
PDMS well in the flow cell. Once cured, the molds were soaked overnight in hexane to 
remove any uncured PDMS. They were then dried at room temperature and rinsed with 
ethanol and purified water.   
To obtain patterned SLBs, the PDMS stamps were put into conformal contact 
with the glass surface in the flow cell and fixed in place with a piece of tape. Next, a 1 
mg/ml fibrinogen solution was injected into the well and incubated for 5 min, forming a 
fibrinogen monolayer on the uncovered portions of the glass. The fibrinogen solution 
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was washed away in a 150 mM NaCl solution before peeling off the PDMS stamp. 
Finally, the desired lipid vesicle solution was introduced into the well. This caused 
supported lipid bilayers to form by vesicle fusion to the portions of the glass support that 
were not blocked by the protein monolayer.
46, 62
 After this, the PDMS block was 
introduced to close the chamber in finishing fabrication of the flow cell. 
pH Titration Curves. Experiments were performed to obtain titration data for 0.5 
mol% ortho-rhodamine B-POPE in POPC bilayers as well as this bilayer containing 20 
mol% POPE, 20 mol% Cholesterol, and 20 mol% POPS. The pH of the bulk solution 
above the bilayers was altered via the continuous flow of pH adjusted by 50 mM 
phosphate buffer. The fluorescence intensity was monitored till a steady state. According 
to the titration data, pH 7.1 was selected as it falls within the pH response range of dye 
molecule and is close to physiological pH. 
Fluorescence Microscopy. A Nikon Eclipse Ti-U fluorescence microscope 
(Tokyo, Japan) equipped with a ProEM 1024 CCD camera (Princeton Instruments) and 
Lumen 200 (Prior Scientific) light source was utilized to take fluorescence images. A 4X 
air objective (N.A. = 0.45) was used for imaging along with a Texas Red filter set 
(Chroma Technology, Bellows Falls, VT). MetaMorph software (Version 7.7.0.0, 
Universal Imaging) was employed to process the images. 
Experimental for Sensing Protein and Small Molecule Interactions 
Protein Labeling Procedure. TbpA solutions were made with 10 mM phosphate 
buffered saline (PBS) at pH 7.2 and a protein concentration of 2 mg/ml. The buffer 
contained 150 mM NaCl and 1 mM NaN3. To label the proteins, 20 μL of 1 M Na2CO3 
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was added to 100 μL of a 2 mg/ml protein solution. Next, 0.3 mg of 5(6)-FAM-SE were 
added to the solution and stored at 4° C for 2 days. Subsequently, the labeled proteins 
were separated from remaining free dye molecules via Bio-Spin columns with Bio-Gel 
P-6.  
Calmodulin was reconstituted from a lyophilized powder by 50 mM HEPES 
buffer containing 150 mM NaCl and 1 mM EGTA to a final concentration of 2 mg/ml. 5 
μL of 1 M Na2CO3 and 1 μL of 10 mg/ml 5(6)-FAM-SE DMSO solution were 
sequentially added to a 50 μL calmodulin solution. The solution was then stored at 4° C 
overnight. Finally, remaining free dye was removed from the labeled protein with a Bio-
Spin column before use. 
pH Titration Curve Measurements. 100 mM Tris/Citrate buffer was prepared at 
pH values ranging from 4.0 to 6.5 by adjusting the pH with NaOH/HCl. 100 mM Tris 
buffer was prepared at pH values ranging from 7.0 to 11.0 by adjusting the pH with 
NaOH/HCl. These pH values were chosen to locate the pKA value of the fluorescein dye 
conjugated to each protein. The pH was obtained with a standard glass electrode setup 
with measurements having an error of ± 0.1 pH units. Titration curves for the dye 
molecules on the proteins were made by adding 5 μL of a fluorescein-labeled protein 
solution to 95 μL of buffer. Fluorescence emission spectra were obtained by a QE 
65000-FL Scientific Grade Spectrometer (Ocean Optics, Dunedin, FL) by setting the 
excitation peak to 488 nm. 
Binding Measurements. For fluorescein-labeled TbpA binding to ThMP, 1 μL of 
1.67 mg/ml dye-labeled TbpA was added to 2 ml of 100 mM Tris/50 mM citrate buffer 
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at pH 6.5 in a QVFL-Q-10 cuvette. In this case, aliquots of 25 μM ThMP in water were 
added to the cuvette to generate different concentrations of ThMP with a 15 min room 
temperature incubation allowed before each measurement. For fluorescein-labeled CaM 
binding to Ca
2+, 6 μL of 1.54 mg/ml 5(6)-FAM labeled CaM was added to 94 μL of 50 
mM HEPES buffer containing 150 mM NaCl and 1 mM EGTA at pH 6.8 in a type 
703M Cuvette (Precision Cell, Farmingdale, NY). Aliquots of either 10 mM or 100 mM 
CaCl2 were introduced stepwise to generate different free Ca
2+
 concentrations with a 1 
min incubation period at 25° C allowed before each measurement. All fluorescence 
emission spectra were obtained with a QE 65000-FL Scientific Grade Spectrometer by 
setting the excitation peak to 488 nm. 
Error analysis of the emission intensity was performed. The fluorescence 
intensity of labeled TbpA protein diluted in buffer solution in a cuvette was found to be 
stable to within 0.4% over 10 min of continuous excitation in the fluorometer. In another 
control, ThMP was introduced into a solution of TbpA and free dye, which led to almost 
no signal change. Moreover, 100 nM biotin and 100 nM adenosine monophosphate 
(AMP) molecules, respectively were introduced to a labeled TbpA solution. This gives 
no signal, indicating that fluorescence modulation is selective to the specific target 
molecule. Is this a repeat of the paragraph below? 
CaM-Ca
2+
 binding measurements described herein have been accompanied by 
control experiments that utilized free dye in solution instead of labeled proteins to 
establish that the signal was indeed due to the putative binding event rather than changes 
in fluorescence caused by dye-analyte interactions. Almost no signal changes were 
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observed in the presence of ThMP. For Ca
2+
, the control assays gave rise to an 
approximately 1% intensity decrease in fluorescence at the highest Ca
2+
 concentration 
employed. This change was probably due to a slight decrease in the bulk pH rather than 
any direct Ca
2+
-fluorescence interaction. In fact, the change was linear with pH and 
could easily be distinguished from the Langmuir isotherm response due to CaM-Ca
2+
 
interactions. 
Experimental for Inexpensive Fluorescence Detector Fabrication 
Fabrication of Microfluidic Device. After soak the Glass slides (soda lime, 
Corning) in a mixed 1:3 (v/v) concentrated hydrogen peroxide and concentrated sulfuric 
acid solution for at least one hour, the slides were rinsed with deionized distilled water 
thoroughly and dried with nitrogen. A thin layer of photoresist (Shipley 1823) was spin-
coated onto the glass slides with several hundred microns in thickness. With a previously 
designed mask attached to the photoresist side of the slide, the slides were exposed to 
UV (> 400 W) for 8-12 seconds after a hard baking procedure (115 
o
C, 1.5 min). A 
developing solution and acetone was then utilized to remove all the exposed photoresist. 
Later on, the glass slides were blew dry and underwent another hard baking process (115 
o
C, 1.5 min). 
Buffered oxide etchant (BOE) solution was prepared by mixing a 1:6 ratio (v/v) 
of 48% hydrofluoric acid (EMD Chemicals Inc., Germany) and aqueous ammonium 
fluoride (200 g in 300 mL purified water, Alfa Aesar, Ward Hill, MA), which was used 
to etch the patterns into the glass slides. The glass was immersed into the BOE solution 
for 2-3 min and 1 M hydrochloride acid solution for 1 min sequentially, which should be 
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repeated at least 4 times before remove the photoresist. After that, the slides were coated 
with triflorododecylsilane.  
PDMS was prepared by mixing 10:1 (v/v) of Sylgard silicone elastomer-184 and 
the curing agent, degassed under vacuum before it was poured over the patterned glass 
slides. Then, the PDMS got annealed in a 65 
o
C oven over night. After treating both the 
annealed PDMS and the cover slip were treated with 25 W oxygen plasma for 60 
seconds, the PDMS was brought into contact with the cover slip. A microfluidic device 
could be obtained as shown in Figure 2.4. 
Fabrication of Inexpensive Fluorescence Detector. The 532 nm laser pointer was 
directly connected to a 3 V DC power supply (Agilen Inc., Englewood, CO) and was 
kept on to give a constant laser out put approximately at 12 mW. The laser pointer was 
mounted on the laser table with a tilted angle to the sample stage in order to avoid the 
direct reflection of the laser light into the camera lens. The schott glass filter (OG. 570) 
was attached to the lens of the camera by double side tape. Black insulation tape was 
utilized to seal the gap between the filter and the camera lens, which might cause the 
leak of light. The camera was just located in front of the sample stage at the same height, 
which was approximately 6 cm, in order to collect as much light as possible while still 
enables manual focusing.  The buffer or analyte solution stage is mounted relatively 
higher than the sample stage for the purpose of gradient driven flow. For an intuitive 
view of the designed device, a schematic figure and a picture for the real device are 
shown in Figure 2.5. 
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Fabrication of Flow Cell. Here, the flow cell is modified based on the flow cell 
previously described. As shown in Figure 2.6, two cover slips served as the ceiling and 
the bottom of the device respectively. A polydimethylsiloxane (PDMS) cover block 
served as the spacer of the device that defines the well volume. Two small holes on 
either side of this block served as inlet and outlet ports for flowing liquid. The PDMS 
block was placed directly over a second thin PDMS film (0.52-0.64 mm) with an 8 mm 
diameter hole in the middle that defined the exposed area of a No. 2 glass coverslip 
placed beneath it. Flowing aqueous solutions came into contact with this exposed area. 
One thin stainless steel plates (6.5 cm by 3.0 cm) with a 1.0 cm diameter hole in the 
center was utilized to reinforce the bottom cover slip. And the whole device is clamped 
together. The thin PDMS film and the thicker PDMS cover block was made the same 
way except as previously described. 
 
  
  
 25 
 
 
Figure 2.4. Schematic Diagram of a Microfluidic Device. The PDMS mold and 
cover slip substrate is covalently bound together. The number of channels within the 
device usually could be made from 2-9 depending on demand. 
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Figure 2.5. Inexpensive Fluorescence Microscope Design. (a) The schematic graph 
that shows the design of the inexpensive fluorescence detector. (b) The real picture of 
the assembled inexpensive fluorescence detector. The laser pointer was mounted tilted to 
the sample stage to avoid the direct reflection of laser light into the camera. On the 
sample stage, a microfluidic device is mounted here.  
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Figure 2.6. Flow Cell for Inexpensive Fluorescence Detector. The diagram shows 
the fabrication of the flow cell and the mounting of the flow cell in the inexpensive 
fluorescence detector. The inlet and outlet hole is drilled on either side of the PDMS 
block instead. 
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CHAPTER III 
SENSING SMALL MOLECULES AND LIPID MEMBRANES 
INTERACTIONS BY LOCAL PH MODULATION* 
Introduction 
A great number of small drug molecules currently on the market target 
membrane localized proteins, such as receptors and ion channels.
28, 29
 These molecules 
can also directly or indirectly interact with the surrounding lipid membrane,
30-33
 which 
may lead to changes in a drug’s function, properties, and availability.34 Thus, it is 
important to understand the intrinsic interactions between drug molecules and lipid 
membranes. As most drugs are small molecules, whose properties may be altered greatly 
upon fluorescent labeling, it is imperative to employ label free methods to study small 
molecule-membrane interactions. A number of techniques have been employed to detect 
these interactions including UV-Vis spectroscopy,
63
 nuclear magnetic resonance 
(NMR),
64-66
 electron paramagnetic resonance (EPR),
67
 quartz crystal microbalance with 
dissipation monitoring (QCM-D),
68
 isothermal titration calorimetry (ITC),
69
 vibrational 
spectroscopy (both infrared and Raman),
70-73
 second harmonic generation (SHG) 
imaging,
34
 ultraviolet-visible sum-frequency generation (UV-Vis SFG),
74
 differential 
scanning calorimetry (DSC),
75, 76
 and fluorescence spectroscopy based on a drug’s 
intrinsic fluorescence.
77
 
_________________________________________ 
*
 
Reprinted with permission from “Sensing Small Molecule Interactions with Lipid 
Membranes by Local pH Modulation” by Huang, D.; Zhao, T.; Xu, W.; Yang, T.; 
Cremer, P. S. Anal. Chem. [Online early access]. DOI: 10.1021/ac401955t. Published 
Online: Oct. 23, 2013. Copyright 2013 American Chemical Society. 
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The methods enumerated above differ widely in their ease of use, signal-to-noise 
limits, expense, and requirements for technically trained operators. For example, QCM-
D is relatively easy to use, but has only modest sensitivity. Sensing based on a drug’s 
intrinsic fluorescence may be quite useful in specific cases, but is not universally 
suitable because of the limited fluorescence of many candidate molecules. On the other 
hand, SHG and UV-Vis SFG are more universal techniques, but require more 
sophisticated equipment and more advanced operator training. Moreover, NMR and EPR 
can potentially provide detailed molecular-level information, but are of limited 
importance in high-throughput screening and have limited sensitivity. Raman and IR 
have better sensitivity, but provide less chemically-specific information and still are 
probably of only limited use in the development of screening assays. Perhaps the most 
widely accepted technique is ITC, which is often used to monitor drug molecule 
interactions with lipid vesicles in solution. Its sensitivity is limited by the degree of 
exothermicity of a given binding event and studies with ITC require highly concentrated 
samples.  
Herein, we will describe a new technique that uses much less lipid material, has 
higher throughput and provides improved signal-to-noise compared with ITC. Moreover, 
this method works with supported lipid bilayers (SLBs),
62, 78, 79
 which affords the ability 
to perform heterogeneous assays. This is a significant development because lipid vesicle 
solutions are employed in ITC in homogeneous assay formats, whereby drug molecules 
are constantly injected into continuously diluted samples. The advantage of 
heterogeneous assays with SLBs is that they can be run with a single lipid bilayer while 
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the adjacent buffer solution is continuously replaced.
80-85
 SLBs have been widely used as 
model cell membranes in vitro,
44, 45
 and can have similar lipid compositions to cellular 
membranes as well as maintain the same two-dimensional fluidity.
79
 Additionally, for 
studying drug-membrane interactions, it is advantageous to employ SLBs instead of 
liposomes, as SLBs require far less sample volume. Moreover, they can be integrated 
into an on-chip platform as part of a microfluidic device. 
The strategy we wished to develop for detecting small molecule-membrane 
interactions is based on pH modulation sensing.
25, 86, 87
 In the case of lipid membranes, 
this involves directly conjugating a pH sensitive dye such as ortho-Texas Red
25
 or ortho-
rhodamine B
87
 to a phosphatidylethanolamine (PE) lipid embedded within a bilayer. 
These two dyes have been tested to show no obvious photobleaching behavior under the 
experimental condition.
25, 27
 Previously, we have shown that assays for target proteins 
can be developed when membrane-conjugated ligands are added to the membrane.
28,30
 
Upon binding of a target protein with a net charge, the interfacial potential is modulated, 
which in turn shifts the protonation state of the pH sensitive dye molecule.
 
This strategy 
is extremely sensitive and can detect target protein concentrations in bulk solution with 
the Kd value several orders of magnitude lower than that for the corresponding ligand-
receptor binding event. As such, we reasoned that it should be possible to extend this 
idea to small molecule-membrane interactions in a heterogeneous assay, in which QCM-
D, SPR, or ITC have more difficulties due to intrinsic signal-to-noise limitations.  
Herein, we demonstrate that the pH modulation approach can be exploited to 
monitor tetracaine-phospholipid interactions with outstanding sensitivity. Tetracaine is 
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an anesthetic drug with a pKA near 8.9 (molecular structure provided in Figure 3.1).
22,88, 
89
 Its main activity is known to involve the blocking of ion channels in cell membranes. 
Extensive investigations of tetracaine-membrane interactions have been made over the 
last several decades. This includes the anesthetic mechanism for this drug,
90, 91
 its 
location within the lipid bilayer,
92, 93
 and the influence of the ionization state of 
tetracaine on its binding properties.
77
 It has been reported that tetracaine inserts into 
biomembranes in the way that the butylamino group resides inside the lipid tale group 
region, while the protonated dimethylamino moiety is positioned near the phosphate 
moiety of the lipid head group.
93
 
For the current experiments, 0.5 mol% ortho-rhodamine B-conjugated POPE 
(oRB-PE) was embedded in POPC bilayers to detect tetracaine (Figure 3.1). The 
experiments were performed at pH 7.1, where the drug bears a positive charge in bulk 
solution. Also, this pH falls within the linear range of the pH titration curves while still 
close to physiological pH (Figure 3.2). Upon introducing the drug, a reversible decrease 
in the fluorescence response from oRB-PE was observed. This is consistent with the 
drug molecule making the interfacial potential more positively charged. By varying the 
drug concentration, it was possible to obtain a binding curve for the tetracaine/membrane 
interaction (Kd = 180 ± 47 µM). Moreover, it was found that this dissociation constant 
could be modulated by varying the lipid composition in the membrane. 
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Figure 3.1. Principles of Drug-Membrane Interaction Sensing. The Schematic 
diagram illustrates the principles of oRB-PE acting as a reporter for drug-membrane 
binding. (Before) In the absence of the drug molecules, the fluorescent dyes are in the 
“on state”, which is shown in in red. (After) Upon binding the drug molecules, the 
interfacial potential is increased, which recruits OH
-
 to the surface. As a result, the dye 
molecules in the lipid membrane are turned off (shown in pink). 
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Figure 3.2. pH Titration Curves for Different Supported Lipid Bilayers. The plot 
shows the titration data for each selected membrane composition. The solid circles 
represent individual fluorescence measurements and the solid lines are guides to the data. 
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Tetracaine-Membrane Interaction Sensing Results and Discussion  
Sensing Tetracaine-POPC Supported Bilayer Interactions. SLBs containing 99.5 
mol% POPC and 0.5 mol% oRB-PE were utilized for sensing tetracaine-membrane 
interactions in an initial series of experiments. This work was performed with 50 mM 
sodium phosphate buffer at pH 7.1 ± 0.1.
87
 The buffer was flowed over the patterned 
bilayers until fluorescence stabilization was achieved (Figure 3.3(a)). Next, tetracaine at 
concentrations ranging from 0-500 μM was introduced into the buffer and continuously 
flowed through the flow cell until the fluorescence intensity from the lipid bilayer 
stabilized. Images were captured every 5 minutes and stabilization took about 30 
minutes at the lowest drug concentration. There are two reasons for the relatively slow 
response time. First, the diffusion process for tetracanine to arrive at the surface from the 
bulk solution takes every more time as the concentration is lowered. Since we are in the 
M range in this experiment, it is not a very significant factor. On the other hand, the 
flow chamber has a dead volume of ~250 L. To replace this solution once takes ~15 
minutes at a flow rate of 1 mL/hour. Thus, the response time could be significantly 
decreased, if desired by using a smaller flow chamber. A representative image after 
equilibration with 500 µM tetracaine is shown in Figure 3.3(b). The individual 
fluorescence line scans for 8 different tetracaine concentrations are shown in Figure 
3.3(c). As can be seen, the fluorescence intensity of the lipid bilayer decreased with 
increasing concentration of the drug molecule. At the highest concentration of tetracaine 
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employed, 500 µM, the fluorescence intensity decreased by more than a factor of three. 
By flowing out the drug molecule, the fluorescence reverted back to the starting intensity 
and, hence, the whole process was completely reversible over at least five cycles of 
introducing and removing tetracaine, which is demonstrated in Figure 3.4. This indicates 
tetracaine can be completely removed from the membrane. The data in Figure 3.3(c) 
represent a signal-to-noise ratio of ~400:1. This corresponds to a detection limit of about 
3 µM at the 99% confidence level under the identical experimental and instrumental 
condition.   
Using the data from Figure 3.3(c), the relative fluorescence intensity decrease 
could be plot as a function of drug molecule concentration (Figure 3.3(d)). The y-axis 
represents the relative fluorescence change ΔF, which is calculated as (F-F0)/F0, which 
reduces to F/F0-1. In this equation, F is the fluorescence intensity of the bilayer as a 
function of tetracaine concentration in the bulk solution, whereas F0 is the fluorescence 
intensity of the bilayer in pure buffer. 
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Figure 3.3. Sensing Tetracaine-POPC Bilayer Interaction. Epi-fluorescence image 
of a stripped bilayer pattern in a flow cell is obtained (a) before and (b) after the 
introduction of 500 μM tetracaine. The scale bars shown in white are 1 mm. (c) Line 
scan profiles for the same patterned bilayer under bulk tetracaine concentrations ranging 
from 0 to 500 μM. The red dash lines in (a) and (b) represent the regions used obtain the 
line scans. (d) Plot of the relative fluorescence intensity change vs. bulk tetracaine 
concentration. The blue solid line is the best fit to a Langmuir isotherm for these data 
points.  
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Figure 3.4. Reversibility Test for Tetracaine-POPC Bilayer Interaction Assay. The 
blue dots are POPC SLB flowed with 50 mM pH 7.1 phosphate buffer, while the red 
dots are POPC SLB flowed with 50 mM pH 7.1 phosphate buffer containing 500 µM 
tetracaine. The flow rate was approximately 1 ml/h. The SLB were stabilized under each 
condition for at least 30 min. 
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The data in Figure 3.3(d) can be fit to a Langmuir isotherm as shown by the blue 
solid line. The apparent equilibrium dissociation constant is abstracted using equation 
3.1: 
     
   
      
                                                            (3.1) 
where T is the bulk concentration of tetracaine and a is a constant corresponding to the 
maximum relative fluorescence intensity change. The fit yields a Kd of 180 ± 47 μM, 
which is consistent with the literature value for this binding event found by non-linear 
optical measurements.
34
 As a control experiment, the direct interaction of tetracaine with 
the dye molecule was probed in bulk solution in a QVFL-Q-10 cuvette within a QE 
65000-FL Scientific Grade Spectrometer. In this case, 1 μM ortho-rhodamine B-
conjugated biotin was placed in a 50 mM sodium phosphate buffer solution (pH 7.1 ± 
0.1). Solution conditions were varied to consist of up to 1 mM tetracaine. No changes in 
the fluorescence intensity were noted within experimental error, even at the highest 
concentration of the drug molecule. 
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Figure 3.5. Detection Limit Assay. The plot shows the fluorescence intensity line 
scan of a POPC SLB under 0.5 mM sodium phosphate buffer (pH 7.1 ± 0.1) without 
tetracaine (blue and green) and with 25 pM tetracaine (red).  
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It should be noted that although the detection limit was 3 μM for the experiments 
in Figure 3.3, this value could easily be lowered by several orders of magnitude by 
simply averaging the data over the entire sample area, making multiple measurements as 
a function of time, or decreasing the buffer concentration by analogy with work done for 
protein-membrane interactions.
25, 87
 For example, by utilizing a 10X objective and 0.5 
mM sodium phosphate buffer solution (pH 7.1 ± 0.1), it was easily possible to detect 25 
pM tetracaine (Figure 3.5) with detection limit of ~10 pM. This measurement was also 
completely reversible after the reintroducing of pure buffer. The reason for the improved 
detection limit under these conditions is the higher light gathering power of the 10X 
objective (NA = 0.30 vs. only NA = 0.13 for 4X object). Moreover, the decrease in the 
ionic strength of the solution led to an increase in the Debye length. This will, in turn, 
allow more distant fluorophores to be effected under otherwise similar experimental 
conditions as we have already shown for protein detection.
25, 27
 An even lower detection 
limit can be achieved by further decreasing the ionic strength. It should be noted, a 
detection limit of ~1 pM tetracaine was achieved by working at 5 M sodium phosphate 
buffer (pH 7.1 ± 0.1). However, the buffering capacity of the solution is eroded as it the 
buffer concentration is lowered. Therefore, there is a trade-off between the limit of 
detection and maintaining a stable pH value. A 5 M buffer seems to represent a 
practical limit for this. 
Effect of Cholesterol on Tetracaine-Bilayer Binding. In a next set of experiments, 
cholesterol was introduced to POPC SLBs with 0.5 mol% oRB-PE and tested for 
tetracaine interactions. Cholesterol is an important constituent in mammalian cells which 
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varies significantly in concentration in the membranes of various organelles.
94, 95
 It 
influences cell membranes via its interactions with lipids and membrane associated 
proteins.
96
 Herein, cholesterol concentrations were varied from 0 mol% to 45 mol%. The 
assays were otherwise carried out under the same conditions as those in Figure 3.3. 
Fluorescence modulation assays were performed with 5 different cholesterol 
concentrations (Figure 3.6(a)) and the values for Kd as a function of cholesterol are 
plotted in Figure 3.6(b). As can be seen, Kd weakened approximately three fold and did 
so in a linear fashion with increasing cholesterol concentration. This attenuation in the 
strength of the tetracaine-bilayer interaction is in agreement with previous reports. 
Specifically, Zhang and co-workers found that 28 mol% cholesterol in DPPC bilayers 
decreased the partition coefficient of tetracaine to the bilayer both below and above its 
phase transition temperature.
77
 Nguyen et al. have shown that a decrease in tetracaine 
binding to SOPC, DMPC, and DPPC bilayers could be observed after incorporating 28 
mol% cholesterol.
34
 Both of these previous studies were, however, performed at just this 
single concentration of cholesterol. Our current data showing a linear weakening of the 
Kd value with the mol% cholesterol in a POPC bilayer is consistent with the notion that 
cholesterol increases the packing density of the lipids in the bilayer and leaves less room 
for the small molecule to insert.
7
 In fact, according to Kim et al., the mean head group 
area per DPPC molecule should decrease linearly with increasing cholesterol 
concentration.
97
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Figure 3.6. Cholesterol Influence on Tetracaine-POPC Bilayer Interaction. (a) Plots 
of relative fluorescence intensity change vs. bulk tetracaine concentration for five 
different cholesterol concentrations: 0, 10, 20, 33, and 45 mol%. The solid lines are the 
best fits to Langmuir isotherms. (b) A plot of Kd vs. cholesterol concentration from the 
data in (a). The red solid line represents the best linear fit to the data. 
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Effect of POPE on Tetracaine-Bilayer Binding. Phosphatidylethanolamine (PE) 
is composed of a glycerol moiety that is esterified with two fatty acids and a phosphate 
group. The negatively charged phosphate group is conjugated to a positively charged 
ethanolamine group, which makes the whole molecule zwitterionic at pH 7.1 ± 0.1. PE 
usually constitutes 20-50% of total phospholipid content in mammalian cells, which 
makes it the second most abundant lipid after phosphotidylcholine (PC).
98
 Thus, it is 
important to discern the influence of PE on tetracaine/membrane interactions. For the 
current studies, POPE was chosen as a model PE lipid, because it has the same tale 
groups as POPC. It should be noted that PE is more basic than PC with pKa = ~9.6 for 
the amino group.
99
  
To test the influence of POPE on tetracaine-bilayer interactions, up to 20 mol% 
POPE was incorporated into POPC SLBs. This upper concentration limit was chosen 
because greater PE concentrations may impede vesicle fusion to the planar glass 
supports.
100
 Binding curve data are provided in Figure 3.7 and the extracted apparent Kd 
values are plotted in Figure 3.8. As can be seen, PE had the opposite effect of cholesterol. 
Specifically, the Kd value for tetracaine binding tightened from 180 ± 47 μM to 124 ± 23 
μM when 20 mol% POPE was added to the SLBs. Once again, the trend appeared to be 
linear with the added lipid component. 
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Figure 3.7. Binding Curves for POPE Bilayers. The figure shows the plots of the 
relative fluorescence intensity change vs. bulk tetracaine concentration from bilayers 
containing various concentrations of POPE. The solid lines re the best fit to Langmuir 
isotherms. 
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Figure 3.8. POPE Influence on Tetracaine-POPC Bilayer Interaction. The figure 
shows the plot of the Kd value for tetracaine vs. the POPE concentration in POPC 
membranes. The red solid line represents a linear fit to the data. 
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The linear increase of tetracaine affinity with increasing POPE concentration 
may attribute to hydrogen bonding between POPE lipids and tetracaine. Several studies 
have demonstrated the ability of PE to form hydrogen bond with various small 
molecules.
101-104
 Herrera et al. demonstrated that there are hydrogen bonds forming 
between an amino acid’s carboxylate group and the R-NH3
+
 from PE when arginine 
interacts with the DMPE bilayer. Moreover, the carbonyl moiety of PE lipid is able to 
form hydrogen bond with the guanidinium moiety of arginine.
101
 Besides, Pink et al. 
have proposed hydrogen bond formation between PC and PE, which would need to form 
between either the NH3
+
 and PO2
−
 or NH3
+
 and C=O.
103
 By analogy, a hydrogen bond is 
likely to form in between the R-NH3
+
 group on POPE and the C=O group on tetracaine.  
It has been observed that the incorporation of PE into phospholipid bilayers 
reduces interchain hydration while enhancing head group hydration.
105
 However, 
because PE lipids have a relatively small and cone shaped head group, it is energetically 
unfavorable to have an increase in head group hydration, which makes planar bilayers 
unstable.
106, 107
 Evidence from a 
31
P-NMR study has shown that tetracaine inserts into 
PE-containing bilayers by acting as a wedge, which helps stabilize the membrane.
108
 As 
such, the relatively stronger affinity between tetracaine and POPE-containing bilayers 
may be the result of relieving the lipid packing constraints caused by the presence of 
POPE. 
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Effect of Negatively Charged Lipids on Tetracaine-Bilayer Binding. In addition 
to uncharged and zwitterionic components, there are also negatively charged lipids in 
bilayers such as phosphatidylserine (PS), phosphatidylglycerol (PG) and gangliosides. 
Although they are not as abundant in biological membranes as PE or cholesterol, 
negatively charged lipids are tightly regulated and play a key role in membrane 
chemistry.
109-114
 Moreover, these components should interact at least electrostatically 
with the positively charged tetracaine. 
Experiments were carried out with POPG, POPS, and GM1 using similar 
conditions and procedures as described above. The buffer for POPG and GM1-
containing SLBs was 50 mM sodium phosphate (pH 7.1 ± 0.1). While the buffer with 
POPS contained 0.8 mM EDTA due to the potential quenching ability of trace 
concentrations of divalent metal ions such as Cu
2+
.
115
 The associated binding curve data 
are provided in Figure 3.9. The apparent dissociation constant for tetracaine as a function 
of each negatively charged lipid components are provided in Figure 3.10. It should be 
noted that data at 30 mol% is only provided for POPG and POPS as vesicles containing 
30 mol% GM1 would have difficulty in forming supported bilayers. 
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Figure 3.9. Binding Curves for Negatively Charged Lipids Contained Bilayers. The 
figures show the plots of the relative fluorescence intensity change vs. bulk tetracaine 
concentration from bilayers containing various concentrations of negative charged lipids: 
(a) GM1 containing bilayers, (b) POPS containing bilayers, and (c) POPG containing 
bilayers. The solid lines are the best fits to Langmuir isotherms. 
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Figure 3.10. Influence of Negative Charge on Tetracaine-POPC Bilayer Interaction. 
The figure shows the plots of the Kd values for tetracaine vs. the mol% of negatively 
charged lipids for PG (blue diamonds), PS (red square), and ganglioside GM1 (green 
triangle). The solid curves represent the best curve fit to the data. 
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As can be seen from Figure 3.10, the influence of POPS, POPG, and GM1 on the 
Kd values are essentially identical. Thus, the effect should be simply electrostatic rather 
than chemically specific. Indeed, the incorporation of any of these three molecules into 
the bilayer will make the surface potential more negative.
116
 This in turn will enhance 
the electrostatic interactions between the bilayer and the positively charged tetracaine 
molecules. Moreover, the presence of negatively charged lipids leads to a tightening of 
the dissociation constant only at lower concentrations of the negatively charged lipid, 
while this effect flattens out as the concentration is increased further. This finding is 
consistent with the idea that the surface potential decreases non-linearly as additional 
negatively charged lipids are introduced into the membrane.
116
 The overall effect is to 
tighten the dissociation constant by approximately a factor of six when 30 mol% of a 
given negatively charged lipid is present (Figure 3.10). 
Comparison with ITC. As noted in the introduction, a variety of methods have 
been employed to investigate the interactions of membranes with small molecules.
63-77
 
As ITC is probably the most commonly employed of these techniques, we wished to 
benchmark the current pH modulation results against it. To do this, ITC measurements 
were performed with a MicroCal Auto-iTC200 (Pittsburgh, Pennsylvania) using similar 
tetracaine-POPC binding conditions described in Figure 3.3. However, since 
measurements could not be made with supported bilayers, 100 nm diameter POPC 
vesicles (0.76 mg/ml) in 50 mM sodium phosphate buffer (pH 7.1 ± 0.1) were used 
instead. In order to obtain a binding curve, 1.5 μL of 10 mM tetracaine aliquots were 
introduced into 370 μL of the vesicle solution in 25 separate injections. A Kd value of 
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126 ± 65 μM was found for this interaction and the detection limit was ~1 µM. 
Experiments were also run with POPC vesicles containing 0.5 mol% oRB-PE. In this 
case we found Kd = 103 ± 53 μM. The raw ITC data and curve fits are provided in Figure 
3.11. Within experimental error, both of these measurements are the same and agree well 
with the data from Figure 3.3 where a value of 180 ± 47 µM for Kd was found. Such ITC 
measurements serve as an additional control to verify that adding 0.5 mol% oRB-PE as a 
probe in the pH modulation assays had little if any effect on the experiment. It should be 
noted that there could be a small difference in the Kd values between the ITC and pH 
modulation experiments since the former was done with vesicles and, thus, have curved 
surfaces, while the supported membranes are essentially flat. Apparently, any binding 
differences caused by this degree of curvature do not lead to significant differences 
within experimental error. 
 There are significant advantages of making drug-membrane interaction 
measurements by the pH modulation technique compared with ITC. One essential factor 
is the relatively small sample amount required in the former case. In fact, in order to 
obtain an acceptable signal from ITC, 400 μL of 0.76 mg/ml vesicle solution must be 
prepared. Moreover, 1.5 μL of highly concentrated (10 mM) tetracaine aliquots were 
introduced into the vesicle solution in 25 separate injections. By comparison, the amount 
of lipid material required in the pH modulation setup was several orders of magnitudes 
less. It should be noted that the pH modulation experiments can also be run in 
microfluidic channels, where only a few microliters of bulk sample would be flowed, 
although that was not done here. Smaller lipid and drug sample volumes would represent 
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a significant advantage when exploring the interactions of expensive or rare drug 
molecules with membranes. Secondly, the pH modulation assay can be run under 
conditions where the detection limit of the assays outstrips ITC by at least 4 or 5 orders 
of magnitude (Figure 3.5). Thirdly, the cost of a typical ITC instrument is over $100,000, 
whereas fluorescence measurements can be made with a setup costing much less than 
this. Finally, the current fluorescence-based technique has the potential for easy 
multiplexing by employing patterned bilayer membranes to explore multiple membrane 
interactions at once.
53, 117
 In fact, dozens, if not hundreds of interactions could be 
explored simultaneously. Such multiplexing advantages would be much more difficult to 
be realized by ITC measurements.  
It should be noted that there are also inherent advantages of ITC. For example, 
this technique directly measures heat transfer, which affords the most straightforward 
way to obtain H values for the drug-membrane interactions. One could also image 
circumstances under which a particular drug might directly interact with the dye 
molecule employed as the probe in the pH modulation sensing assay. Finally, both 
methods provide thermodynamic information and can thus benefit from complementary 
spectroscopy measurements such as FTIR, Raman, or NMR to provide molecular level 
details concerning drug-membrane interactions. 
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Figure 3.11. ITC Data for Tetracaine-POPC Bilayer Interaction. ITC data for (a) 
pure POPC vesicles and (b) POPC vesicles containing 0.5 mol% oRB-PE are shown in 
the graphs above. The top graphs show individual heat spikes as sample injections are 
made. The bottom graphs are the plots of the evolved heat vs. the molar ratio of 
tetracaine introduced into solutions containing POPC vesicles. And the solid lines are the 
best nonlinear regression fits to the data and the extracted Kd values are provided in the 
main text. 
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Conclusions 
As demonstrated above, our pH modulation sensor platform can be employed to 
measure Kd values for the interactions of tetracaine with phospholipid membranes, 
which could be easily applied to study other drug molecules such as ibuprofen, aspirin, 
and saxagliptin.
118-120
 Drug-membrane binding should arise largely from van der Waals, 
hydrophobic, packing, hydrogen bonding, and electrostatic interactions.
77, 93, 101
 The Kd 
value measured for the interaction of tetracaine with supported POPC bilayers was 180 ± 
47 µM. This value could be modestly weakened by adding cholesterol to the membrane 
(Kd = 350 µM with 33 mol% cholesterol) or modestly tightened by adding POPE or 
negatively charged lipids to the membrane (Kd = 35 µM with 30 mol% DOPG).  Each 
set of measurements could be made within a few minutes. Also, the surface area covered 
by the lipid bilayer involved less than 10
15
 lipid molecules, since the surface coverage 
inside the flow device was under 1 cm
2
. This platform offers a facile and rapid method 
for the detection of interactions between drug molecules and lipid bilayers, especially 
when compared with ITC. Thus, it may be developed into a rapid screening assay and 
used in a multiplexed format to detect interactions with many different types of lipid 
membranes simultaneously. 
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CHAPTER IV 
MONITORING PROTEIN-SMALL MOLECULE INTERACTIONS  
BY LOCAL PH MODULATION* 
Introduction 
Measurements of the affinity of biomolecular interactions, such as protein-
protein binding, protein-small molecule binding, and protein-ion binding not only 
provide insight into basic cellular processes but can also facilitate the development of 
therapeutics and serve as the basis for many diagnostic techniques.
35
 To date, numerous 
efforts have been made to monitor such ligand-receptor interactions. One potential 
drawback is that the devices associated with these techniques can be bulky, insensitive, 
and/or difficult to use. For example, calorimetric methods, such as isothermal titration 
calorimetry (ITC),
121-123
 directly measure the heat associated with a given binding 
process. However, this method has relatively low sensitivity and usually requires large 
sample volumes. Moreover, it cannot be utilized if binding causes only very modest 
enthalpic changes. Interfacial methods, such as Surface Plasmon Resonance,
124, 125
 
microcantilever sensing,
126
 and nanowire sensing
127
 permit detection down to the pM 
level and sometimes below it. Nevertheless, the requirement of immobilizing 
biomolecules onto surfaces can potentially cause problems. For example, the receptor 
sites on a protein might face the surface, inhibiting the binding process. Also, surface 
_________________________________________ 
* Part of the data reported in this chapter is reprinted with permission from Biosens. 
Bioelectron., 38, Huang, D.; Robison, A. D.; Liu, Y.; Cremer, P. S., “Monitoring 
protein–small molecule interactions by local pH modulation”, 74-78, Copyright 2012, 
with permission from Elsevier. 
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immobilization may influence the conformation and activity of the immobilized protein 
via partial or complete denaturation.
128
  
Recently, Bornhop et al. (2007) developed Back-Scattering Interferometry (BSI) 
to study biomolecular interactions in bulk solution.
35
 This method affords label-free 
ligand-receptor measurements with good sensitivity. It operates by exploiting the fringe 
patterns which are generated when a laser beam is shined onto a microfluidic channel in 
a direction perpendicular to the long axis of the channel. Shifts in the fringes arise when 
the refractive index of the solution inside the channel is changed. These shifts can be 
interpreted in terms of ligand-receptor binding with the aid of appropriate software.  
Despite elegant advances such as BSI, there remains a pressing need to develop 
simple fluorescence-based techniques which can operate in bulk aqueous media. Indeed, 
fluorescence techniques can be sensitive down to the single molecule level
25, 129, 130
 and 
are readily compatible with 96, 384, and 1536-well plate screening platforms.
131-133
 
Moreover, fluorescence assays are highly portable and can be used in conjunction with 
simple battery-operated, hand-held devices.
134
 Efforts have been made to utilize 
fluorescence resonance energy transfer (FRET) techniques to study protein-ligand 
interactions or sense protein substrates.
135, 136
 However, in order to obtain a FRET signal, 
two specially selected fluorescent dyes are required, one donor fluorophore and one 
acceptor fluorophore. These must be labeled on specific sites of the biomolecules,
137, 138
 
which can decrease the simplicity of such an approach.  
Herein, we utilize a simple fluorescence-based biosensor assay which exploits a 
pH-sensitive fluorescent dye. The dye, 5-(and-6)-carboxyfluorescein, is strongly 
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fluorescent at high pH values and less fluorescent at low pH. Indeed, this dye is sensitive 
to any factors that can influence the local chemical environment, such as changes in the 
local dielectric constant or local electric field. The physical principle for this method is 
based on the idea that the pH sensitive probe can be placed in proximity to a protein 
binding pocket by conjugation to free lysine residues via succinimidyl ester-linkages. 
The apparent pKa of the dye will be modulated when charged ligands bind or through 
rearrangements due to allosteric effects. A schematic illustration of this concept is shown 
in Figure 4.1. In the example, a capture protein (shown in orange) is conjugated with 
fluorescein dyes. These fluorophores initially have relatively strong fluorescence, which 
decreases upon the binding of a target ligand (shown in purple). In this rendition, the 
platform is a “turn off” sensor. This can be the case if the target ligand is negatively 
charged at the operating pH. It will recruit hydronium ions around the capture protein 
environment and consequently help protonate the fluorescein probe. Alternatively, if the 
target ligand induces a conformational change in the protein upon the binding event, this 
may also influence the local chemical environment and thus modulate the intensity of the 
dye. 
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Figure 4.1. Principles of Protein-Small Molecule Interaction Sensing. (Before) In 
the absence of the target protein, the dye molecules conjugated to the capture protein are 
in the “on state”. (After) Upon binding the target ligand, the negatively charged target 
ligand will recruit hydronium ions and decrease the local pH around the protein. As a 
result, the dye molecules on the capture protein are turned off. 
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In order for the present method to be effective, the pH sensitivity of the 
fluorescent probe should fall within the region of interest for measuring ligand-receptor 
interaction. One simple choice is 5- (and 6-) carboxyfluorescein, which has its largest 
fluorescence variation between pH 6.0 and pH 7.4.
139
 As the dye molecule is 
deprotonated, its fluorescence is “turned on”. Thus, this dye is an excellent reporter 
candidate for many biomolecular interaction assays.  
Herein, we demonstrate the use of fluorescein as a local pH sensor on proteins 
for monitoring the interaction of proteins, small molecules, and ions, specifically 
observing Staphylococcal aureus Protein A (rSPA) with human IgG, thiamin 
monophosphate (ThMP) with thiamin binding protein A (TbpA), and Ca
2+
 with 
calmodulin (CaM). This platform is quite versatile and appears to be generically useful 
for monitoring protein-ion and protein-small molecule interactions. 
Protein-Small Molecule Interaction Sensing Results and Discussion  
Titration Curves for Fluorescein-labeled Proteins. In the first set of experiments, 
titration curves of fluorescence intensity vs. solution pH were obtained for fluorescein 
conjugated to TbpA and CaM. The experiments were performed by using solutions of 
varying pH ranging from acidic to basic. Fluorescence spectra obtained at multiple pH 
values are provided in Figure 4.2. As expected, the conjugated dye molecules showed 
higher florescence intensity at more basic pH values and lower intensity at relatively 
acidic pH. The titration curves were not strongly influenced by the specific protein to 
which the dyes were attached. The apparent pKAs were 7.0 ± 0.1, 6.5 ± 0.1, 6.4 ± 0.1, 
and 6.4 ± 0.1 for rSPA, IgG, TbpA and CaM, respectively.   
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Figure 4.2. pH Titration Curves for Labeled Proteins. Single measurements of 
relative fluorescence intensity of 5(6)-FAM as a function of pH for different proteins are 
shown in the graphs above. (a) rSPA, (b) IgG, (c) TbpA, and (d) CaM. The blue lines 
represent guides to the eye for the titration curves. 
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Binding Curves for rSPA and IgG. The FC region of IgG molecules binds to 
rSPA in a trivalent fashion. Human and rabbit IgGs have been reported to bind with 
avidities ranging from Kd = 0.016 nM to 161.3 nM.
140-142 
 Upon rSPA-IgG binding, the 
fluorescence intensity increases if 5(6)-FAM was labeled on rSPA and decreases if 5(6)-
FAM was labeled on IgG, as shown in Figure 4.3. This is because the pIs of rSPA and 
IgG are 5.1
143
 and 7.2 – 8.6144, respectively, which results in increasing the local 
hydronium ion activity around rSPA and decreasing it on IgG after binding.  
For the 5(6)-FAM labeled rSPA, the experiment was conducted at pH 7.08, 
which is located in the linear range of the 5(6)-FAM titration shown in Figure 4.2(a). A 
concentration of 4.7 mg/mL IgG in PBS buffer was gradually added to the cuvette. This 
should initially result in mostly monovalent binding while progressing towards 
multivalent binding with increasing IgG concentration. The binding curve shown in 
Figure 4.4(a) could be fit by a Langmuir isotherm equation (4.1):  
                 
        
               
       (4.1) 
where [IgG]o denotes the IgG concentration added, [PrSPA]o is the total concentration of 
the binding pocket on rSPA, which should be three times of the initial concentration of 
rSPA.    is the dissociation constant, F  is the relative fluorescence change |1-F/F0|，
where F and 0F  indicate the integrated average fluorescence intensity from 520 nm to 
530nm. Also,   is a constant that describes the relationship of the fluorescence change to 
the concentration of substrate bound protein. The    value extracted from this model is 
38.2 nM, which corresponds well with literature values.
141
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Figure 4.3. rSPA-IgG Binding Induced Fluorescence Intensity Change. (a) The 
fluorescence increases after adding IgG to 5(6)-FAM labeled rSPA. (b) The fluorescence 
decreases after adding rSPA to 5(6)-FAM labeled IgG. The difference in signal-to-noise 
ratios stems from the different total number of fluorophores present in the system when 
rSPA vs. IgG is labeled.  
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It should be noted that this equation differs from a standard Langmuir isotherm 
made with a surface containing immobilized receptor sites in contact with a bulk liquid. 
That is because the liquid can typically be flowed over the surface continuously until 
equilibrium is achieved. By contrast, in bulk solution one has a fixed number of binding 
pockets of rSPA proteins and these are titrated with IgG. As such, only the added 
amount of IgG is controlled and some of these molecules are bound while the rest are 
unbound. In this case, it is assumed that the fluorescence change should be directly 
related to the formation of the PrSPA -IgG complex: 
                                                                  (4.2) 
Here [] denotes concentration, k is a constant representing the intrinsic relationship 
between the relative fluorescence change and the PrSPA -IgG complex concentration. 
According to the definition of the dissociation constant, one can write: 
            (                    )(                  )           (4.3) 
where []o denotes the initial concentration or the added concentration. Combining 
equation (4.1) and equation (4.2) generates an equation (4.1) describing the relation of 
relative fluorescence intensity change and IgG concentration. 
For the 5(6)-FAM labeled IgG, the assay was run at pH 6.5, which is at the center 
of the slope shown in Figure 4.3(b). Here the binding process will decrease the 
fluorescence intensity. A concentration of 0.5 mg/ml rSPA in PBS buffer was gradually 
added to the cuvette.  This should initially result in multivalent binding before becoming 
monovalent at higher IgG concentrations. In contrast to the assay described above, 
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labeling the IgG did not result in a binding curve that could be fit by a simple Langmuir 
isotherm (Figure 4.4(b)). Instead, the data were fit with a Hill plot equation (4.4): 
         
 
 
          
    (            )
 
(            ) 
     (4.4) 
The    value extracted was 1.77 nM, which also falls into the range of reported rSPA-
IgG dissociation constants. The Hill coefficient n was 0.32, which indicated an anti-
cooperative binding process.  
Binding Curve for TbpA and ThMP. TbpA is the thiamin periplasmic-binding 
protein from E. coli,
145
 which has been shown to bind ThMP with modestly high affinity, 
having a reported Kd around 2.3 nM.
146
 The acidic phosphate group on the ThMP 
molecule brings down the local pH around the binding site of TbpA, thus making the 
binding of ThMP to TbpA observable via the fluorescence intensity decrease of dye-
labeled TbpA. The assay pH was chosen to be 6.5, which is located just above the 
middle of the slope in Figure 4.2(c). TbpA and ThMP bind in a 1 to 1 ratio and a 
Langmuir isotherm could be employed to fit the data for the titration curve in Figure 
4.4(c): 
               
       
             
                            (4.5) 
The extracted dissociation constant of 3.2 ± 0.7 nM matches well with the 
literature value and the detection limit for ThMP is 2.1 nM. This assay provides direct 
evidence that the pH modulation technique is capable of following small molecule-
protein binding events. 
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Binding Curve for CaM and Ca
2+
. CaM, the ubiquitous Ca
2+
 binding protein, was 
chosen to demonstrate the ability of this method to follow protein-ion interactions. It is 
known that this protein can bind to and regulate a multitude of different protein targets.
35, 
147
 Most studies have suggested that CaM contains either multiple classes of binding 
sites for Ca
2+
 or negative cooperativity.
148-150
 Literature Kd values for CaM-Ca
2+ 
binding 
vary from 1 to 10 μM.35, 151 In the current assay, the operating pH was 6.8, which is at 
the top of the linear range of the titration curve (Figure 4.2(d)). Interestingly, the binding 
of Ca
2+
 to CaM leads to a decrease in fluorescence signal, which indicates that the 
charge on the cation is not the dominant factor in changing the fluorescence response of 
the dye. CaM contains eight lysine residues, three of which are located within Ca
2+
 
binding domains and one of which is C-terminally located. This C-terminal lysine is 
most likely to be labeled by the dye, and will experience a large conformational change 
based upon crystal structure analysis,
152
 which results in a decrease in fluorescence 
intensity. The binding curve is shown in Figure 4.4(d). Note that EGTA is added to the 
buffer to help maintain the free Ca
2+
 concentration at a constant level.
153
 The data are 
modeled using a Langmuir isotherm fit equation (4.6):  
            
      
      
   
                                              (4.6) 
Next, the relative fluorescence change from this binding process can be 
designated as δF. A constant, k, is needed to relate to CaM-Ca2+ complex formation. 
From these, an equation describing the relationship between the relative fluorescence 
intensity change and Ca
2+
 concentration can be written as: 
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                                    (4.7) 
The abstracted equilibrium dissociation constant was 1.1 ± 0.07 μM and the detection 
limit for Ca
2+
 was 0.16 μM.  
The dissociation constant values measured for the two processes described above 
along with literature values are summarized in Table 4.1.  
 
Table 4.1. Dissociation Constants for Protein-Small Molecule Interaction. 
Binding partners  
Measured 
Kd 
Values  
Literature 
Kd 
Values  
Detection method of 
published data  
Protein A(FAM) -  
IgG  
38.2 nM  
0.16–160 
nM  
Acoustic waveguide141 and 
others140, 142  
IgG(FAM) – Protein 
A  
1.77 nM  
0.16–160 
nM  
Acoustic waveguide141 and 
others140, 142  
TbpA(FAM) – 
ThMP  
3.2 nM  2.3nM  
Intrinsic protein fluorescence 
measurement146 
CaM(FAM) – 
Calcium 
1.1 µM  1–10 µM  
Equilibrium and flow 
dialysis151  
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Figure 4.4. Binding Curves for Protein-Small Molecule Interaction. Plots of the 
relative fluorescence intensity change (|1-F/F0|) vs. substrate concentration for two 
labeled protein-substrate binding systems are shown in the figure. The solid curves 
through the data are the best fits to equations. 4.1, 4.4, 4.5 and 4.7, respectively. (a) The 
plot for the 5(6)-FAM labeled rSPA/IgG pair. (b) The plot for the 5(6)-FAM labeled 
IgG/rSPA pair. (c) The plot for the 5(6)-FAM labeled TbpA/ThMP pair. (d) The plot for 
the 5(6)-FAM labeled CaM/Ca
2+
 pair. 
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Conclusions 
We have developed a novel pH dependent assay for monitoring protein/substrate 
binding in bulk solution. This method is quite general as the assay can be employed for 
protein/protein, protein/small molecule, and protein/ion binding in a similar fashion. The 
anticipated magnitude of the relative fluorescence intensity change decreases as one 
move from large entities such as proteins to small molecules and ions. For the rSPA/IgG 
interaction assay, the maximum relative fluorescence change was around 50 percent. 
This is because proteins are larger species with multiple charges on them, which will 
strongly influence local pH after binding. However, for the TbpA/ThMP assay, because 
ThMP is a small molecule with fewer charges on it, the maximum relative fluorescence 
change is only around 16 percent. Finally, for the CaM/Ca
2+
 assay, Ca
2+
 ions are 
supposed to recruit hydronium ions which should increase the local pH and turn on the 
fluorescence. However, the conformation-induced local pH change induces a decrease in 
fluorescence, which ultimately dominates the signal. These competing effects result in 
an apparent relative fluorescence change that is even smaller.  
As long as ligand-receptor binding sites are located within the Debye length of 
the pH sensitive dye, the conjugated fluorophore will be sensitive to the binding of a 
ligand molecule. Under physiological conditions (about 100 mM salt), the Debye length 
is typically on the order of 1-2 nm. Therefore, each conjugated dye will work as a local 
sensor that investigates the pH around a few square nanometers of protein surface area. 
The binding of a ligand to the binding pocket of a protein will modulate the protonation 
of D, E, K, R, and H residues as well as cause the protein to undergo a conformational 
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change. Both of the effects will ultimately modulate the local electric fields in the 
vicinity of the fluorescent probe. In our assay, the binding of rSPA to FAM-labeled IgG 
decreases the fluorescence intensity, while the binding of IgG to FAM-labeled rSPA 
increases the fluorescence intensity. This is expected in accordance with pI values of 
those proteins, though there may well be additional effects due to binding-induced 
conformational change. However, for the CaM/calcium pair, the observed signal is 
certainly due to a conformational change of CaM upon calcium binding because a 
decrease in fluorescence is observed rather than an increase, considering that the binding 
of Ca
2+
 should increase the local pH on electrostatic grounds. Therefore, local changes 
near the dye molecule due to allosteric effects apparently override this change.  
A key advantage of the pH modulation technique is its ability to separately 
monitor both entities in a multivalent binding reaction by simply reversing the labeling 
on the binding pair. For rSPA/IgG, it was possible to label rSPA and obtain a saturation 
binding curve that followed simple Langmuir isotherm behavior. On the other hand, 
labeling the IgG led to non-Langmuirian behavior with a Hill coefficient of 0.32. This 
value represented a strong negative cooperativity effect. Such negative cooperative may 
be due to the steric hindrance that occurs when multiple IgG molecules bind to the same 
rSPA. Indeed, the IgG is much larger than rSPA. The different results when applying the 
assay in one direction, i.e. adding the IgG to the rSPA, as opposed to the reverse may be 
due to the multivalent binding behavior of IgG-rSPA, the details of which warrant 
further analysis in the future.  
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In summary, the pH modulation technique is quite simple and sensitive. The 
assay just needs one simple labeling process, as opposed to Förster resonance energy 
transfer (FRET) techniques, which require labeling of two different fluorescent dyes at 
specific sites. Also this method utilizes a fluorometer, which is common in most labs, to 
demonstrate nM sensitivities. This sensitivity can be optimized if specific site labeling of 
fluorophores is utilized. This would help to reduce background fluorescence from dyes 
that are far away from the binding sites and are thus eliciting no response.   
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CHAPTER V 
DESIGN AND ASSEMBLY OF INEXPENSIVE  
FLUORESCENCE DETECTOR 
Introduction 
A fluorescence microscope is an optical microscope that utilizes fluorescence 
and phosphorescence emission in addition to, or instead of, absorption and reflection of 
white light in studying properties of biological or non-biological substances.
154
 The 
generation of a fluorescence image could be through several kinds of set up, such as epi-
fluorescence microscope, which is the simplest one, and confocal microscope, which 
utilizes optical sectioning in order to obtain a fluorescent image with better resolution. 
With a wide variety of commercial available fluorescence dye molecules and fluorescent 
proteins, as well as different labeling methods, fluorescence sensing method provides 
target-specific, high-contrast images possible for quantitative, multiplexed and 
automated data analysis.
155-159
 As a result, the measurement of förster resonance energy 
transfer (FRET), fluorescence recovery after photobleaching (FRAP), single molecule 
fluorescence study et al. has been made feasible.  
In our laboratory, the epi-fluorescence microscope is the major device utilized in 
monitoring the fluorescence intensity in the label free pH modulation based sensing 
assays. This equipment is also very common in life science related laboratories. The 
design of such a microscope is schematically illustrated in Figure 5.1. The excitation 
light is generated by selecting out the right wavelength light with a band pass filter from 
the white light emitted by a mercury lamp. This emission light is later reflected by a 
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dichroic mirror and focused by an objective lens to the sample stage. The emitted 
fluorescence light are collected by the objective lens, filtered by the long pass emission 
filter, and finally directed to the detector that is usually a deep cooled CCD chip. The 
sensitivity of such an epi-fluorescence microscope mostly depends on the numerical 
aperture of the objective lens, which defines the angle that the system can accept the 
light from, and the cooling temperature for the CCD chip, which eliminates the thermo 
noises. 
Although there are great advantages for these fluorescence microscopes, they do 
have inherent disadvantages of high cost, large size, and limited field of view.
160
 An 
alternative fluorescence imaging system that could resolve these drawbacks can greatly 
compensate the deficiency of fluorescence microscopes in certain assays.  
Previously, we developed fluorescence pH modulation bio-sensing platform, 
which has been demonstrated to be quite powerful in detecting protein-target interactions 
and drug-membrane interactions. During the development of this sensing platform, we 
used fluorescence microscopes to monitor the fluorescence intensity all the time. 
However, an expensive and bulky fluorescence microscope leads to high assay cost and 
limits the utilization of this method within a laboratory. With a brief research over the 
web, it’s found that key components in a fluorescence microscope could be substituted 
by the commercialized cameras, schott glass filters, and the laser pointers, which have 
been well developed with pretty low cost on market. Thus, we were engaging in 
designing and building up a family affordable fluorescence detector costing under 
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several hundred dollars. The capacity of this device in our pH modulation assay was 
demonstrated by monitoring tetracaine-POPC SLB interaction.  
 
Figure 5.1. Schematic Diagram of Epi-fluorescence Microscopy. The excitation 
light is generated by a mercury lamp. A filter set is utilized to filter out the excitation 
and emission light. And a CCD detector is used for the detection of fluorescence 
emission intensity. 
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Inexpensive Fluorescence Detector Fabrication Results and Discussion 
Device Fabrication. Considering that ortho-rhodamine B dye was utilized in our 
pH modulation bio-sensing platform,
25, 27
 a 532 nm laser pointer was selected as the 
excitation light source. Schott OG-570 coated glass filter that claimed to have its optical 
density value higher than 3 below the wavelength of 550 nm was utilized as the filter for 
the emission light. And a Cannon SX-120 powershot camera with manual operation 
mode was used as the detector. The fabrication has been introduced in Chapter II and 
shown in Figure 2.5. 
Laser Illumination Characterization. Other than avoiding the direct reflection of 
laser light into the camera lens that may cause huge background noise, mounting the 
laser pointer at an angle to the sample stage could change a the shape of the laser from a 
small round point to a elongated ellipse. This enables the illumination over a short range 
that may cover all the channels on a single microfluidic device. However, this elongated 
ellipse laser spot needs to be uniform enough for direct comparison among the intensity 
of those microfluidic channels. To characterize this illumination, approximately 3 µm 
thick MICROPOSIT S1813 photoresist was spin-coated onto a large microscope glass 
slide. The glass slide was then mounted onto the sample stage on the fluorescence 
microscope and monitored by the mounted deep cooled CCD. The illumination was 
switched between the mounted Prior Scientific Lumen 200 Fluorescence Illumination 
System and the tilted laser pointer. As shown in Figure 5.2, the line scan over the 
illuminated area indicates the tilted laser pointer could give a relatively even  
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Figure 5.2. Intensity Scan for Excitation Illumination. The figure shows the 
intensity line scans over the illuminated area by Lumen 200 Fluorescence Illumination 
System (Blue) and tilted laser pointer (Pink) respectively. 
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illumination over the whole illuminated area, which has no obvious vignetting 
phenomenon and is comparable to the Lumen 200 Fluorescence Illumination System. 
Also, the existing illumination inhomogeneity could be adjusted simply by background 
subtraction. 
System Characterization. Noise level, which determines the detection limit in 
sensing assays, is an important property of a system. In our case, this noise level majorly 
depends on the performance of the detector, which relies on the cooling temperature. 
Through deep cooling method, it could help reduce dark current and improve the CCD 
sensitivity. However, on the simplest design, it is not realistic to adopt a deep cooling 
system to the Canon camera in our inexpensive fluorescence detector, which may 
impede the portability of designed device. As a result, it requires testing the signal to 
noise level of the inexpensive fluorescence detector in order to estimate its performance 
compared to a fluorescence microscope. On the other hand, our pH modulation sensing 
platform monitors the fluorescence intensity of the sample, which correlates with the 
concentration/amount of the analyst. This correlation is believed to be linear if the 
intensity measured from an image is proportional to the actual fluorescence intensity 
emitted from the sample. Thus, to switch to our inexpensive fluorescence detector for pH 
modulation assays, it is necessary to prove that this kind of linear response still exists.  
To test the signal to noise ratio and the linear response of fluorescence intensity 
of our inexpensive fluorescence detector and compare the results with the fluorescence 
microscope, a microfluidic device with different concentrations of POPC lipid vesicles 
with 0.5 mol% para-rhodamine B-POPE lipid in 50 mM pH 7.0 PBS buffer in each 
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channel is monitored by both system. As shown in 5.3(a) and 5.3(b), our inexpensive 
fluorescence detector could obtain a decent fluorescence picture of the sample in the 
microfluidic device, which is similar to the picture obtained from the fluorescence 
microscope system. The line scan over these two pictures (Figure 5.3(c) and 5.3(d)) 
gives an estimation of signal to noise ration for these two systems respectively. For the 
fluorescence microscope, the signal to noise ratio is 175, while for the inexpensive 
fluorescence detector the value is 42. Although the signal to noise ratio of inexpensive 
fluorescence detector is over four times less than the fluorescence microscope, this 
signal to noise ratio could still be enough for the general measurement in our pH 
modulation assays. By taking and overlapping multiple pictures for the same device, it is 
feasible to greatly decrease this noise level and increase the sensitivity. With several 
repeats and averaging the intensity data, the linear response of the inexpensive 
fluorescence detector is demonstrated (Figure 5.3(f)), which is comparable to the 
fluorescence microscope (Figure 5.3(e)). The large error bar in Figure 5.3(f) is mostly 
due to the relatively higher noise level of the system. 
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Figure 5.3. System Characterization. The measurement of the linear response of 
fluorescence intensity from fluorescence microscope system and our inexpensive 
fluorescence detector is shown. (a) is the picture taken from the microscope system, and 
(b) is the picture taken from our inexpensive detector. The yellow dot line indicates the 
location of the intensity line scan. The white solid line is the scale bar, which is 0.5 mm. 
(c) and (d) shows the intensity line scan of (a) and (b) respectively. (e) and (f) 
summarize the averaged data and shows the linear response of microscope system and 
our inexpensive fluorescence detector with increasing concentration of dye labeled 
vesicles in the injected buffer solution.   
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Figure 5.4. Application of Inexpensive Fluorescence Detector. (a) The fluorescence 
pictures obtained by our inexpensive fluorescence detector on the POPC bilayer in the 
flow cell under different bulk tetracaine concentrations (0-500 μM). The yellow dot line 
indicates the location of the intensity line scan. The white solid line is the scale bar, 
which is 1 mm. (b) Line scan profiles for the pictures in (a). (c) Plot of relative 
fluorescence intensity change vs. bulk tetracaine concentration. The red solid line is the 
best Langmuir isotherm fit to the data points. 
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Flow Cell Measurement. Based on these characterizations, this newly designed 
inexpensive fluorescence detector was utilized to monitor the fluorescence intensity in 
our pH modulation assay. Initially, the experiment was carried out with a flow cell, 
which is similar to the one used in chapter III. And SLBs containing 99.5 mol% POPC 
and 0.5 mol% oRB-PE were utilized. This work was performed in 50 mM sodium 
phosphate buffer at pH 7.1 ± 0.1.
87
 The buffer was flowed over the patterned bilayers 
until fluorescence stabilization was achieved. Next, tetracaine at different concentrations 
ranging from 0-500 μM was introduced into the buffer and continuously flowed through 
the flow cell until the fluorescence intensity from the lipid bilayer stabilized. Images 
were captured after 30 minutes’ stabilization. 
A series of images after equilibration with 0-500 µM tetracaine with phosphate 
buffer are shown in Figure 5.4(a). It is very obvious that the intensity of this orange dot, 
which is the fluorescence emission from the POPC SLB, decreased with increasing 
concentration of tetracaine molecule. The individual fluorescence line scans for 8 
tetracaine concentrations, indicated as yellow dot lines in Figure 5.4(a), are shown in 
Figure 5.4(b). At the highest concentration of tetracaine employed, 500 µM, the 
fluorescence intensity decreased by more than a factor of three. 
Using the data from Figure 5.4(b), the relative fluorescence intensity decrease 
could be plot as a function of drug molecule concentration (Figure 5.4(c)). The y-axis 
represents the relative fluorescence change ΔF, which is calculated as (F-F0)/F0, i.e. 
F/F0-1. In this equation, F is the fluorescence intensity of the bilayer as a function of 
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tetracaine concentration in the bulk solution, whereas F0 is the fluorescence intensity of 
the bilayer in pure buffer. 
The data in Figure 5.4(c) can be fit to a Langmuir isotherm as shown by the red 
solid line. The apparent equilibrium dissociation constant is abstracted using equation 
5.1: 
     
   
      
                                                            (5.1) 
where T is the bulk concentration of tetracaine and a is a constant corresponding to the 
maximum relative fluorescence intensity change. The fit yields a Kd of 266 ± 43 μM, 
which is consistent with the literature value for this binding event found by non-linear 
optical measurements.
34
  
Discussion. In the current design and assembly method, all the parts are fixed in 
place on a laser table. This device could give a decent signal to noise ratio compared to a 
deep cooled CCD chip on a fluorescence microscope when the fluorescence emission 
intensity is strong enough as shown in Figure 5.3, in which dye labeled vesicle solutions 
were utilized. However, when the sample’s fluorescence intensity is pretty weak, such as 
the fluorescence emitted from SLBs, the noise level increased dramatically, which limits 
the sensitivity a lot. Thus, in the future development of this kind of device, a proper 
cooling method may be designed without too much cost. And dark paper may be needed 
to absorb all the diffracted light.  
On the other hand, it worth noting that there is no lock and key like fitting site on 
the sample stage for the device mounted such as the flow cell here. Thus, double side 
tape was utilized for the mounting purpose. Although this kind of tape works perfectly in 
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fixing the device in place, it is very difficult to remount the device at exactly the same 
place on the sample stage in different repeated experiments. This could lose the 
repeatability of the assay and cause a lot of effort in re-aligning the laser pointer and the 
camera. In order to solve this problem, it is planed to design and make a 3D plastic box 
that has all the pre-designed mounting sites for each component. Also, such a box could 
enable the adopting of a cooling system and some other light blocking and absorption 
pieces. 
Finally, with the technology development in recent years, almost every cell 
phone has an integrated camera. These integrated cameras sometimes are even better 
than an individual camera on aspects like resolution and sensitivity. If a cell phone 
integrated camera could be utilized in our device, it will make the design even more 
portable and cost efficient as there will be no need in having an extra camera. However, 
in current design, a manual function for the camera is necessary, which most of the cell 
phone integrated cameras do not have. If the camera is in auto mode, slight setting 
change when taking the images will make it impossible to compare two pictures and 
extract useful data. For example, in the flow cell attempt, if the exposure time is 
different for those images in Figure 5.4(a), the intensity data from the line scan will no 
longer be valid for comparison. Also, the weak fluorescence light makes it very difficult 
for auto focusing. We believe by just including a simple program that enables manual 
controlling the camera could resolve the conflict easily. And this will be the future 
direction of the development. 
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Conclusions 
As a conclusion, it has been successfully demonstrated that our newly designed 
and built inexpensive fluorescence detector could give a decent signal to noise ratio in 
fluorescence intensity measurement compared to the fluorescence microscope. Later on, 
this fluorescence detector was utilized in the pH modulation assays in which the 
interaction between tetracaine, an anesthetic drug molecule, and POPC SLB was studied. 
Although the signal to noise ratio is not as good as a fluorescence microscope in the 
sensing assays, by averaging the data, it is still able to obtain the correct 
thermodynamics data. 
By comparison, our inexpensive fluorescence detector has several advantages. 
Firstly and most importantly, this inexpensive fluorescence detector is really cheap, 
which only costs couple of hundred dollars in total. This price is approximately 2-3 
orders of magnitude less than that of an epi-fluorescence microscope. Such cheap price 
will enable the possession of this inexpensive fluorescence detector for each single 
family, which promotes the everyday application of those fluorescence based assays. 
Also, this price could be even lowered if the cell phone camera is utilized. Secondly, this 
newly designed fluorescence detector is portable. The microscope part of an epi-
fluorescence microscope, which has many delicate parts, is quite heavy in tens of 
kilograms. As a result, the microscope could only be set on certain flat and sturdy 
surfaces, avoiding being moved too frequently. Also, the deep cooled CCD detector and 
the mercury lamp have never been considered to be portable as they are also relatively 
big in size. With our new design, the whole weight of the detector will be less than 5 
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kilograms. And the size of this detector could be smaller than 20 cm
3
. Thirdly, this 
detector could be developed into an automated detector that does not need specially 
trained operators. With the help of a designed plastic box, each component could be 
fixed in place and tuned by mini-motors. It is believed that with the help of a simple 
computer program, the automated sensing could be realized. 
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CHAPTER VI 
CONCLUSIONS 
We have developed a new label free fluorescence based pH modulation sensing 
method that makes use of a pH sensitive fluorescent dye in sensing the local pH changes 
of a SLB upon the binding between a ligand and a receptor on the SLB surface. It is able 
to tune the sensing pH range by adjusting the buffer concentration as well as the buffer 
ionic strength. Based on the previous study, this sensing platform has been successfully 
applied in the field of monitoring drug-membrane interactions. Tetracaine, a well-
studied anesthetic drug, has been selected as the model drug. By utilizing the pH 
modulation method, it is able to obtain the thermodynamics data of the interaction 
between tetracaine and POPC SLB. The composition of the bilayer could be modulated 
with the incorporation of nature cell membrane components, such as cholesterol, POPE 
lipid, and some negatively charged lipids. This enables the study and analysis on how 
the nature of different membrane components influences the interaction between the 
drug molecule and the SLB. In the future, it is anticipated that this kind of technique 
could be utilized in new drug development, in which this could be used in screening out 
the target drug molecule that has anticipated proper interaction with the cell membrane. 
Also, this method could be used for the study of drug-membrane protein interactions, 
which is under development in our laboratory.  
Based on the prototype of this pH modulation sensing platform, it is very useful 
if this assay platform could be extended for homogeneous studies, such as protein-target 
association measurement. By comparison, a protein backbone could work as the lipid 
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bilayer that accommodates the target molecule recognition site and the pH sensitive 
fluorescence dye molecules. Through the demonstration on sensing rSPA-IgG, TbPA-
ThMP, and Calmodulin-Ca
2+
 interactions, pH modulation based sensing method has 
been successfully extended to a homogeneous sensing platform. With the success of this 
design, it is hoped that this kind of sensor could be applied in detection small molecules 
and ions selectively, such as detecting the pollutant of Hg
2+
 in the river around Texas.  
Finally, the high cost and cumbersome of a fluorescence microscope could 
inevitably prevent the wide application of our newly developed sensing platform. To 
address this issue, a design for an inexpensive microscope substitute was carried out. A 
common camera, a schott glass filter, and a 532 nm laser pointer could be enough for the 
substitution of the key components on a fluorescence microscope. And all of these only 
cost several hundred dollars. Based on these components, an inexpensive fluorescence 
detector was successfully built, characterized, and tested in the study of tetracaine-POPC 
SLB interaction. Still, this kind of inexpensive fluorescence detector is under further 
development. Firstly, we designed a plastic box to fix each component in place. Several 
mini motors could be utilized to tune the direction of the laser pointer, the sample stage, 
and the camera. The cell phone integrated camera could be used to substitute the Canon 
camera here to further bring down the cost of the device and increase the portability of it.  
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